EHAB Stock Recent News
EHAB LATEST HEADLINES
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enhabit (EHAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. The presentation can be found at investors.ehab.com/2024-annual-meeting/. The Enhabit Board of Directors iss.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024 are entitled to vote at the 2024 Annual Meeting. The Company issued the following letter to Enhabit Stockholders to address misstatements made b.
NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX” or “we”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit”), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit's recent communications. The full text of the letter can be found here: AREX Sets the Record Straight. We believe voting for all seven of AREX's nominees on the WHITE proxy ca.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the fil.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”) today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the “SEC”) in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital M.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Tuesday, June 11, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Ho.
Enhabit, Inc. (NYSE:EHAB ) Q1 2024 Earnings Conference Call May 9, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President, CEO Crissy Carlisle - CFO Conference Call Participants A.J. Rice - UBS Jason Cassorla - Citi Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health and Hospice's First Quarter 2024 Earnings Conference Call.